Tactile Systems Technology, Inc. (TCMD) Stock

Tactile Systems Technology, Inc., a pioneering medical technology company based in Minneapolis, Minnesota, specializes in the development and delivery of advanced medical devices tailored for chronic disease management across the United States.

At the forefront of its offerings is the Flexitouch Plus system, a cutting-edge pneumatic compression device designed specifically for the treatment of lymphedema. This innovative system provides therapeutic benefits by aiding in the reduction of swelling and improving lymphatic circulation.

Complementing its lymphedema solutions, Tactile Systems Technology also provides the Entre system, a portable pneumatic compression device designed for at-home treatment of venous disorders. These disorders include chronic venous insufficiency and venous leg ulcers, enhancing patient comfort and therapeutic outcomes.

Further expanding its portfolio, the company offers the AffloVest, a portable high-frequency chest wall oscillation therapy device. This technology is pivotal in managing conditions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders by aiding in the clearance of retained pulmonary secretions, thereby improving respiratory health and quality of life for patients.

Established in 1995, Tactile Systems Technology continues to advance its mission of providing innovative and effective medical solutions. Through ongoing research, development, and strategic partnerships, the company remains dedicated to enhancing patient care and addressing critical medical needs in chronic disease management.